scholarly journals Nek2-targeted ASO or siRNA pretreatment enhances anticancer drug sensitivity in triple-negative breast cancer cells

2013 ◽  
Vol 42 (3) ◽  
pp. 839-847 ◽  
Author(s):  
JAEHYUNG LEE ◽  
LAUREN GOLLAHON
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Anticancer Drug ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Drug Sensitivity ◽  
Triple Negative

Half-sandwich Os(ii) and Ru(ii) bathophenanthroline complexes: anticancer drug candidates with unusual potency and a cellular activity profile in highly invasive triple-negative breast cancer cells

2018 ◽  
Vol 47 (35) ◽  
pp. 12197-12208 ◽  
Author(s):  
Jitka Pracharova ◽  
Vojtech Novohradsky ◽  
Hana Kostrhunova ◽  
Pavel Štarha ◽  
Zdeněk Trávníček ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Anticancer Drug ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Cellular Activity ◽  
Activity Profile ◽  
Drug Candidates ◽  
Half Sandwich

A half-sandwich Os(ii) bathophenanthroline complex is a potent agent against highly progressive, poorly treatable triple-negative breast cancer cells.

MiRNAs-181a/b as Predictive biomarkers for olaparib sensitivity in triple-negative breast cancer cells.

2017 ◽  
Vol 12 (1) ◽  
pp. 221-229
Author(s):  
Abeer M. Ashmawy ◽  
Mona A. Sheta ◽  
Faten Zahran ◽  
Abdel Hady A. Abdel Wahab
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative ◽  
Predictive Biomarkers

microRNA-506-3p suppresses the proliferation of triple negative breast cancer cells via targeting SNAI2

2021 ◽  
Vol 17 (4) ◽  
pp. 513-522
Author(s):  
Xuye Zhao ◽  
Xiangdong Bai ◽  
Weina Li ◽  
Xuezhen Gao ◽  
Xiaoli Wang ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Cells ◽  
Triple Negative Breast Cancer ◽  
Breast Cancer Cells ◽  
Triple Negative
Sign in / Sign up

Export Citation Format

Share Document